Buch, Englisch, 2624 Seiten, Format (B × H): 159 mm x 256 mm, Gewicht: 1434 g
Buch, Englisch, 2624 Seiten, Format (B × H): 159 mm x 256 mm, Gewicht: 1434 g
ISBN: 978-1-4743-1032-1
Verlag: LexisNexis UK
Written by some of the most eminent IP practitioners, The Modern Law of Patents offers a fresh, and comprehensive exposition of the law relating to patents in the UK and Europe, including before the Unified Patent Court.
Updates in the new fourth edition will include:
* Supreme Court's decision in Eli Lilly v Actavis [2017] UKSC 48 and the revival of a doctrine of equivalents;
* The new threats provisions under the Intellectual Property (Unjustified Threats) Act 2017 and its relationship to malicious prosecution following Willers v Joyce [2016] UKSC 43;
* Declarations of obviousness: Fujifilm Kyowa Kirin Biologics v Abbvie Biotechnology Ltd [2017] EWCA Civ
* The effect on employee compensation following Shanks v Unilever [2017] EWCA Civ 2;
* The Unitary Patent Court, including the Protocol on provisional applications (PPA) and the most recent (18th) draft of the Rules of Procedure;
* Developments in IPEC practice, including the costs ramifications of PPL v Hagan [2016] EWHC 3076 (IPEC) [although there is talk of this being reversed by an amendment to the CPR];
* The developments in cases on damages and account of profits case law
* Standards Patents and FRAND damages: Unwired Planet International Ltd v Huawei Technologies Co. Ltd & Anor [2017] EWHC 711 (Pat)
* Settlements and competition law: T-472/13 Ludbeck ECLI:EU:T:2016:449 (on appeal C-591/16).
* An exploration of the likely effects of Brexit on patent law;
* All the developments in practice under the Patents Act 1977, the Patent Cooperation Treaty and at the European Patent Office.
The Modern Law of Patents jetzt bestellen!
Updates in the new fourth edition will include:
* Supreme Court's decision in Eli Lilly v Actavis [2017] UKSC 48 and the revival of a doctrine of equivalents;
* The new threats provisions under the Intellectual Property (Unjustified Threats) Act 2017 and its relationship to malicious prosecution following Willers v Joyce [2016] UKSC 43;
* Declarations of obviousness: Fujifilm Kyowa Kirin Biologics v Abbvie Biotechnology Ltd [2017] EWCA Civ
* The effect on employee compensation following Shanks v Unilever [2017] EWCA Civ 2;
* The Unitary Patent Court, including the Protocol on provisional applications (PPA) and the most recent (18th) draft of the Rules of Procedure;
* Developments in IPEC practice, including the costs ramifications of PPL v Hagan [2016] EWHC 3076 (IPEC) [although there is talk of this being reversed by an amendment to the CPR];
* The developments in cases on damages and account of profits case law
* Standards Patents and FRAND damages: Unwired Planet International Ltd v Huawei Technologies Co. Ltd & Anor [2017] EWHC 711 (Pat)
* Settlements and competition law: T-472/13 Ludbeck ECLI:EU:T:2016:449 (on appeal C-591/16).
* An exploration of the likely effects of Brexit on patent law;
* All the developments in practice under the Patents Act 1977, the Patent Cooperation Treaty and at the European Patent Office.
Zielgruppe
Solicitors specialising in copyright, patents, trademarks and IP, Barristers, International Bar Association, Biotechnology and pharmaceutical research companies, Academics, Law libraries
Bitte ändern Sie das Passwort
